The TaiAx life science joint venture led Rakuten Medical's $100 million Series F.
Rakuten Medical, Inc
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox® platform, which has been shown to induce rapid and selective cell killing and tumor necrosis.